Document is current
Any future updates will be listed below
-
Authors
Chotsiri, Palang
Mahamar, Almahamoudou
Diawara, Halimatou
Fasinu, Pius S.
Diarra, Kalifa
Sanogo, Koualy
Bousema, Teun
Walker, Larry A.
Brown, Joelle M.
Dicko, Alassane
Gosling, Roly
Chen, Ingrid
Tarning, Joel
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct02535767 at ClinicalTrials.govDocuments that mention this clinical trial
Population pharmacokinetics of primaquine and its metabolites in African males
https://doi.org/10.1186/s12936-024-04979-y
-
Funding
Funding for this research was provided by:
Wellcome Trust (220221, 220221)
Bill and Melinda Gates Foundation (INV-006052)
- License Information
-
More Information
Article History
Received: 26 September 2023
Accepted: 9 May 2024
First Online: 21 May 2024
Declarations
:
: This study was approved by the Ethics Committee of the Faculty of Medicine, Pharmacy, and Dentistry, University of Science, Techniques and Technologies of Bamako (approval no. 2015/89/CE/FMPOS), and by the Committee on Human Research at the University of California, San Francisco (institutional review board approval no. 14-14495). It also underwent human subjects review at the US Centers for Disease Control and Prevention and approved as non-engagement in human subject research. The trial was registered at ClinicalTrials.gov (registration no. NCT02535767).
: The confidentiality of the participants’ records has been observed according to ethical regulations.
: All authors declare that they have no competing interests.
